Nexalin Technology Booming After Feature on CBS News


Bringing Results for Anxiety, Depression and Insomnia patients without medication!!

Tustin (I-Newswire) December 9, 2013 - Nexalin Technology makes the mainstream news on WPEC-TV CBS 12 News. CBS 12 featured a breaking news piece on Nexalin Technology and how it has been helping a long time depression patient of Dr. Mark Agresti, psychiatrist and owner of Mark Agresti's M.D. & Associates. Dr. Agresti is one of many medical professionals that have set up a Nexalin treatment center within his practice, and he is continuously getting positive results from his patients being treated for Anxiety, Depression and Insomnia. Dr. Agresti is only one of many medical professionals starting to take notice of the increasing success of Nexalin. Well-known medical professionals and world renowned medical facilities have taken much interest in Nexalin and inquiries for Nexalin Technology have largely increased after CBS News featured its booming success.

Link to view the actual CBS News coverage can be found at the end of this release.

Nexalin Technologies, Inc. Founder and CEO Randall Letcavage could not be happier with the success practitioners and patients are having, and with the recent growth Nexalin is experiencing that includes prominent medical professionals and leading medical facilities. Letcavage stated, "This past year we have experienced vibrant growth in Nexalin and are now very pleased to see that our efforts are making a difference in people's lives." Letcavage added, "Nexalin has helped hundreds of patients over the past few years and Nexalin has been growing rapidly through target marketing and word of mouth alone. Now, many well-known medical facilities and treatment centers are adopting Nexalin and the mainstream media is beginning to take notice. I believe we are the future of brain based health."

About Nexalin Technology, Inc.
Nexalin is a device that creates a frequency waveform that seems to affect key brain structures that are involved in the regulation of its neurochemistry. Data suggests the Nexalin waveform effectively resets the hypothalamus of the brain, without the introduction of pharmaceutical medication. Clinical research indicates that a process of normalizing the production of various neurotransmitters, including Dopamine, Serotonin, and Norepinephrine will begin at the beginning of the initial treatment protocol. In recent studies, patients report on average, 80% to 97% of sustained improvement in all symptoms. Clients sit in a comfortable relaxing atmosphere for 40 minutes at a time. Most patient protocols are 10-20 sessions over a 2-4 week period. Three pads are placed gently on your forehead and behind each ear. The stimulating waveform is virtually undetectable, and the treatment is soothing and relaxing. Most patients report a deep relaxing sleep during each treatment. During the treatment, clinical evidence suggests that the hypothalamus and mid-brain are gently stimulated with a repetitive wave form that seems to support certain brain function resets. Further research indicates that the treatment is long lasting with no harmful or serious side effects. More information on Nexalin Technology, Inc. can be found at: http://www.nexalintechnology.com/. If you are seeking supplemental support, or if you are a medical professional looking to learn more, please call for more information: (714) 258-8004.

About Mark Agresti
Dr. Agresti's practice focuses on providing a top quality treatment of mental illness addictions and dual diagnosis. He has expanded his addictions practice to include outpatient detoxification from both drugs and alcohol. His patient population includes both children and adults. He has been in private practice in West Palm Beach, FL for 20 years and has been on the staff of Columbia Hospital and several Addiction Treatment centers. He served as Chairman of the Department of Psychiatry at Columbia Hospital and medical director for the various treatment centers. He has been using Nexalin for the past year and has been experiencing the tremendous results that the therapy can provide. Dr. Agresti says having patient's outcome like Young's is not uncommon, "60% of people say it's dramatic, really life changing, and 20% report significant benefits." More information on Mark Agresti's M.D. & Associates, including testimonials, can be found at: http://dragresti.com/nexalin/.

About Mark Agresti's M.D. & Associates
Dr. Agresti has developed a state-of-the-art detoxification and treatment program for effective substance abuse treatment. He has successfully treated addictions to both prescription and street drugs, as well as alcohol, in an outpatient setting. Treatment may include involvement in Dr. Agesti's Cognitive Restructuring Program, work with a sober coach, and psychotherapy. Cognitive Restructuring is based on principles very different from traditional 12 Step programs, but patients who are involved or prefer the 12 Step Model are encouraged to continue with meetings. There are a variety of methods and places that "do" detoxification. There is no one-size-fits-all program. The essential component of Dr. Agresti's program is an individualized medical and psychological plan. If the substance of abuse is one or more substances, Mark Agresti's M.D. & Associates deals with the total individual, not the drug. They work with the individual to meet their personal goals for changing their habits while meeting their detoxification needs as well as dealing with withdrawal symptoms. Inpatient programs will "detox" the individual but not deal with the long term withdrawal symptoms or teach individuals what is needed to succeed in beating the substance that is controlling them.
Check out the CBS News video here: http://www.cbs12.com/news/top-stories/stories/vid_11316.shtml




Additional Images

       


About Nexalin Technology

Nexalin is a short program that is FDA-cleared to treat anxiety, depression, and insomnia. The nonin   More..vasive Nexalin device transmits a relaxing frequency waveform that reaches the hypothalamus, the area responsible for normalizing brain chemistry. More important, it accomplishes this without resorting to potentially harmful pharmaceutical drugs. Studies indicate that a six-week Nexalin treatment can change the levels of various neurotransmitters, including dopamine and serotonin, leading to long-term relief from the underlying causes of anxiety, depression, and insomnia. The success rate of the Nexalin therapy for these symptoms is 90%. Pharmaceuticals may be the treatment of choice but now there are natural options.Less..

Contact Information

Nexalin Technology
Ryan Reynolds
1382 Valencia Ave
Suite F
92780
Phone : 7142588004

Tags:

anxiety   Depression   insomnia   ADI   Nexalin  

Published in:

Medical > Mental Health

Published On:

December 9, 2013

Print Release:

Print Release

Visit Nexalin Technology Website

If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the I-Newswire.com press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.